Coagulation System (Part II) Flashcards

1
Q

Must be tested within 24 hours of the time of collection

A

PT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Must be tested within 4 hours of the time of
collection

A

APTT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PT reagents (or thromboplastin, tissue thromboplastin) consists of:

A

tissue factor
phospholipids
calcium chloride.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

It is most sensitive to factor VII deficiencies

A

Prothrombin Time (PT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Is used most often to monitor the e ects of
therapy with Coumadin

A

Prothrombin Time (PT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Prolonged PT results in:

A

• DIC
• Liver disease
• Vitamin K deficienc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Is employed to monitor the e ects of UFH and to detect LAC and specific coagulation factor antibodies (anti-factor VIII antibody)

A

Partial Thromboplastin Time (APTT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Is prolonged in all congenital and acquired procoagulant deficiencies (except VII and XIII)

A

Partial Thromboplastin Time (APTT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

PTT Negatively charged particulate activator

A

kaolin, ellagic acid, silica, or celite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PTT Is prolonged when there is a deficiency of one or more of the following coagulation factors:

A

• II, V, VIII, IX, X, XI, XII
• I (if <100 mg/dL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Most common deficiencies of PTT

A

• Factor VIII (Hemophilia A)
• Factor IX (Hemophilia B)
• Factor XI (Rosenthal syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Distinguish LACs from specific inhibitors and factor deficiencies

A

PTT Mixing Studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In PTT Mixing Studies UFH may be neutralized with

A

polybrene or heparinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Commercially prepared bovine thrombin reagent cleaves fibrinopeptides A and B from plasma fibrinogen to form a detectable fibrin polymer

A

Thrombin Clotting Time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Is used to determine whether UFH is present
whenever the PTT is prolonged

A

Thrombin Clotting Time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

May also assess the presence of the oral direct
thrombin inhibitor dabigatran.

+ drug = markedly prolonged

A

Thrombin Clotting Time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

provides quantitative measure of dabigatran

A

Plasma-diluted TCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Reptilase is a thrombin-like enzyme isolated from the venom of

A

Bothrops atrox (lancehead viper)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Venom Activated Assays:

Cleaves fibrinopeptide A only

A

Reptilase Time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Venom Activated Assays:

Useful for detecting hypofibrinogenemia or
dysfibrinogenemia

A

Reptilase Time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Russell Viper Venom (RVV) from the

A

Daboia russelii viper

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Venom Activated Assays:

triggers coagulation at the level of factor X

A

Russell Viper Venom Test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

List the Coagulation Factor Assays

A
  1. Fibrinogen Assay
  2. Single-Factor Assays using the PTT
  3. Nijmegen-Bethesda Assay
  4. Single-Factor Assays using the PT
  5. Factor XIII Assay
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Clot-based method of Clauss

A

Fibrinogen Assay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
• A modification of TCT •Is the recommended procedure for estimating fibrinogen function
Fibrinogen Assay
26
Reagents of Fibrinogen Assay
• Owren buer • Bovine thrombin
27
Explain what happened in Single-Factor Assay using the PTT
● Factor VIII-depleted PPP (alone): ➡️ prolonged PTT ● Factor VIII-depleted PPP + Normal patient plasma: ➡️ PTT reverts to normal ● Factor VIII-depleted PPP + Factor VIII-deficient patient plasma: ➡️prolonged
28
Confirms and quantifies anti-factor VIII inhibitor (typically IgG4-class immunoglobulin)
Nijmegen-Bethesda Assay
29
The principles and procedures described in the section on single-factor assay using the PTT system may be applied except that PT reagent replaces the PTT reagent in the test system, and the PT protocol is followed
Single Factor Assays using the PT
30
is defined as any single or multiple coagulation factor or platelet deficiency
Coagulopathy
31
Accounts for most instances of fatal hemorrhage
Trauma-Induced Coagulopathy
32
Resembles the pathophysiology of TTP
Trauma-Induced Coagulopathy
33
TIC Management
✅ Plasma ✅ FP-24 ✅ VWF and Factors V and VIII activities decline to approximately 60% after 5 days of refrigerator storage
34
the key TIC management component
Plasma
35
alters the production of the Vitamin K-dependent factors
Liver Disease Coagulopathy: Procoagulant deficiency
36
In Liver Disease Coagulopathy: Procoagulant deficiency this serves as the sensitive early marker
Factor VII
37
In Liver Disease Coagulopathy: Procoagulant deficiency this is a more specific marker of liver disease
Factor V
38
During Dysfibrinogenemia, the fibrin is coated with excessive
sialic acid
39
Treatment to Resolve Liver Disease-Related Hemorrhage
1. Oral or intravenous vitamin K therapy 2. Plasma transfusion
40
Is often associated with platelet dysfunction and mild to moderate mucocutaneous bleeding (anemia and thrombocytopenia)
Chronic Renal Failure and Hemorrhage
41
In Chronic Renal Failure and Hemorrhage this coat the platelets
Guanidinosuccinic acid or phenolic compounds
42
is a state of increased glomerular permeability associated with a variety of conditions
Nephrotic syndrome
43
In Nephrotic syndrome, what are detected in the urine
factors II, VII, IX, X, XII, antithrombin, protein C
44
Vitamin K Antagonists
Warfarin (Coumadin) Coumadin overdose: PIVKA factors
45
disrupts the vitamin K epoxide reductase and vitamin K quinone reductase reactions
Warfarin (Coumadin)
46
the single most common reason for hemorrhage-associated emergency department visits
Coumadin overdose
47
the most common acquired autoantibodies
Autoanti-factor VIII
48
Factor Inhibitors other than Autoanti-factor VIII
1. Antiprothrombin antibodies 2. Autoanti-factor XIII 3. Autoantibodies to factor V 4. Autoanti-factor X
49
Factor Inhibitors other than Autoanti-factor VIII Develop as lupus anticoagulant
Antiprothrombin antibodies
50
Factor Inhibitors other than Autoanti-factor VIII Documented in patients receiving isoniazid treatment for tuberculosis
Autoanti-factor XIII
51
Factor Inhibitors other than Autoanti-factor VIII May arise spontaneously in autoimmune disorders and after exposure to bovine thrombin in fibrin glue
Autoantibodies to factor V
52
Factor Inhibitors other than Autoanti-factor VIII In amyloidosis
Autoanti-factor X
53
The most prevalent inherited mucocutaneous bleeding disorder
von Willebrand Disease
54
Leads to decreased platelet adhesion to injure vessel walls
von Willebrand Disease
55
Describe the 3 domains in vWF
Domain A: supports the receptor site for collagen and GP Ib/IX/V Domain C: provides a site that binds GP IIb/IIIA Domain D: provides the carrier site for factor VIII
56
● Caused by autosomal dominant frameshifts, nonsense mutations, or deletions ● Comprises 40-70% of vWD cases
Type 1 von Willebrand Disease
57
Arises from an autosomal dominant point mutations in A2 and D1 structural domains of the vWF molecule
Subtype 2A
58
VWF is susceptible to ADAMTS-13
Subtype 2A
59
Mutations within the A1 domain
Subtype 2B
60
Raised anity to GP Ib/IX/V
Subtype 2B
61
"gain-of-function" mutation
Subtype 2B
62
A platelet mutation that raises GP Ib anity for normal HMW-VWF multimers
Platelet-type vWD (PT-VWD) or pseudo-VWD under Subtype 2B
63
Possesses poor platelet receptor binding despite generating a normal multimeric distribution pattern in electrophoresis
Subtype 2M
64
Missense mutation in the D9 domain impairs the protein's factor VIII binding site
Subtype 2N
65
Factor VIII deficiency despite a normal VWF antigen concentration assay result, normal VWF activity, and a normal multimeric pattern
Subtype 2N
66
Subtype 2N is also known as
Autosomal Hemophilia
67
"Null allele" VWF gene translation or deletion mutations
Type 3 von Willebrand Disease
68
Is the most rare form of VWD
Type 3 von Willebrand Disease
69
Von Willebrand Disease Treatment
PRICE (protection, rest, ice, compression, elevation)
70
Also called Christmas disease
Hemophilia B
71
Also called Rosenthal syndrome, Factor XI deficiency
Hemophilia C
72
More than half of the cases have been described in Ashkenazi Jews
Hemophilia C
73
an eective form of therapy of Factor V Deficiency
Platelet concentrate